XML 78 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
Investments in Equity Securities (Summary of Financial Data) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Sep. 30, 2023
Sep. 30, 2022
Schedule of Equity Method Investments [Line Items]          
Net revenues $ 24,483 $ 25,096 $ 26,013    
Gross profit 14,284 14,246 13,992    
Earnings (losses) from continuing operations 10,928 7,389 3,824    
Net earnings (losses) 8,130 5,764 2,475    
Current assets 5,585 7,220      
Current liabilities 11,319 8,616      
ABI [Member]          
Schedule of Equity Method Investments [Line Items]          
Net revenues 59,841 57,267 52,864    
Gross profit 32,371 31,588 30,653    
Earnings (losses) from continuing operations 7,956 7,879 7,434    
Net earnings (losses) 7,956 7,879 7,434    
Net earnings (losses) attributable to equity investments 6,284 5,838 5,780    
Current assets       $ 22,835 $ 24,164
Long-term assets       188,003 182,087
Current liabilities       35,407 32,649
Long-term liabilities       91,791 96,497
Noncontrolling interests       11,231 11,778
Other Investments [Member]          
Schedule of Equity Method Investments [Line Items]          
Net revenues 87        
Gross profit 9        
Earnings (losses) from continuing operations (105)        
Net earnings (losses) (108)        
Net earnings (losses) attributable to equity investments $ (108)        
Current assets       918 963
Long-term assets       232 274
Current liabilities       31 38
Long-term liabilities       3 8
Noncontrolling interests       $ (3) $ (3)
JUUL and Cronos          
Schedule of Equity Method Investments [Line Items]          
Net revenues   947 1,313    
Gross profit   525 757    
Earnings (losses) from continuing operations   (521) (800)    
Net earnings (losses)   (521) (800)    
Net earnings (losses) attributable to equity investments   $ (520) $ (798)